← Back to Search

Indirect Calorimetry Device

Indirect Calorimetry Devices for Mechanically Ventilated Children

N/A
Recruiting
Research Sponsored by Boston Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age > 10 years AND weight > 10kg
PEEP < 8
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour/participant
Awards & highlights

Study Summary

This trial will compare the Q-NRG+ indirect calorimetry device to the Vmax Encore indirect calorimetry device to see if they provide similar minute-to-minute measurements of oxygen consumption and carbon dioxide production.

Who is the study for?
This trial is for children over 10 years old and weighing more than 10kg who are on mechanical ventilation with specific settings. They must not have severe lung leaks, be unstable in their blood pressure, or be receiving end-of-life care.Check my eligibility
What is being tested?
The study is testing the Q-NRG+ device against the standard V(max) Encore device to measure oxygen consumption and carbon dioxide production in ventilated children to see if they agree on results.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring devices, there are minimal expected side effects related directly to the use of these devices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 10 years and weigh more than 10kg.
Select...
My breathing support settings are low.
Select...
My child is on a ventilator through a tube or tracheostomy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour/participant
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 hour/participant for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Calculated total testing time, including calibration, required to complete a steady state indirect calorimetry measurement using the Q-NRG+ device and the V(max) Encore.
Mean bias and limits of agreement between measured oxygen consumption (VO2) and carbon dioxide elimination (VCO2) in mechanically ventilated children assessed using the Q-NRG+ indirect calorimetry device and the V(max) Encore indirect calorimetry device.

Trial Design

2Treatment groups
Experimental Treatment
Group I: V(max) Encore Indirect Calorimetry DeviceExperimental Treatment1 Intervention
V(max) Encore device, currently institution's standard device, will be compared to Q-NRG+ device in each enrolled patient in subsequent, alternating fashion.
Group II: Q-NRG+ Indirect Calorimetry DeviceExperimental Treatment1 Intervention
Q-NRG+ device will be compared to current V(max) device in each enrolled patient in subsequent, alternating fashion.

Find a Location

Who is running the clinical trial?

Boston Children's HospitalLead Sponsor
761 Previous Clinical Trials
5,579,690 Total Patients Enrolled
Nilesh M Mehta, MDStudy DirectorBoston Children's Hospital
2 Previous Clinical Trials
2,014 Total Patients Enrolled

Media Library

Q-NRG+ Indirect Calorimetry Device (Indirect Calorimetry Device) Clinical Trial Eligibility Overview. Trial Name: NCT04482556 — N/A
Q-NRG+ Indirect Calorimetry Device (Indirect Calorimetry Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04482556 — N/A
Metabolism Research Study Groups: Q-NRG+ Indirect Calorimetry Device, V(max) Encore Indirect Calorimetry Device
Metabolism Clinical Trial 2023: Q-NRG+ Indirect Calorimetry Device Highlights & Side Effects. Trial Name: NCT04482556 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Dec 2024